Date:
Live Webcast: Tuesday, January 15, 2008
Archive: The recorded Webcast is available to watch/listen to until June 12, 2008

Topic:
Is the convergence of drugs, devices and diagnostics leading to innovative health solutions, new opportunities for business growth and product differentiation in the life sciences industry? Issues discussed include:

• Major challenges involved in selecting and managing a pathway to convergence, including investment risks, regulatory uncertainties and issues related to partnerships and alliance networks
• Frameworks for evaluating investment options, defining a convergence approach and partnering effectively
• Leading practices for making collaboration work at individual and organizational levels

Learn key challenges in the development of combination products and how to address potential pitfalls to achieve the potential of convergence.

Host: 
Steve Burrill, partner, Deloitte & Touche LLP

Presenters:
Terry Hisey, vice chairman and U.S. Life Sciences leader, Deloitte LLP
Christine Cote, M.D., CCFP, vice president, Emerging Technologies & New Ventures, Johnson & Johnson

Duration: 1 hour

Sign Up (free; registration required) to watch/listen to the archived Webcast.

Related Content:
Report: Managing Pathways to Convergence in the Life Sciences Industry 
Services: Life Sciences